VivoSim Labs, Inc. (VIVS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 1.89M USD | Liabilities, Current |
| Cash and equivalents | 1.67M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 29.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.89M | $1.67M | (m) | $29.00K | (m) | (m) |
| 2026-03-31 | (m) | $2.79M | $5.02M | (m) | $32.00K | (m) | (m) |
| 2025-12-31 | (m) | $2.48M | $4.29M | (m) | $33.00K | (m) | (m) |
| 2025-09-30 | (m) | $2.45M | $6.68M | (m) | $32.00K | (m) | (m) |
| 2025-06-30 | (m) | $2.14M | $9.05M | (m) | $32.00K | (m) | (m) |
| 2025-03-31 | (m) | $3.74M | $11.31M | (m) | $30.00K | $0.00 | (m) |
| 2024-12-31 | (m) | $2.94M | $1.16M | (m) | $26.00K | $0.00 | (m) |
| 2024-09-30 | (m) | $2.41M | $3.17M | (m) | $29.00K | $640.00K | (m) |
| 2024-06-30 | (m) | $2.03M | $6.19M | (m) | $48.00K | $408.00K | (m) |
| 2024-03-31 | (m) | $1.86M | $2.90M | (m) | $33.00K | $297.00K | (m) |
| 2023-12-31 | (m) | $1.70M | $5.29M | (m) | $33.00K | (m) | (m) |
| 2023-09-30 | (m) | $1.60M | $7.62M | (m) | $55.00K | (m) | (m) |
| 2023-06-30 | (m) | $1.77M | $10.75M | (m) | $149.00K | (m) | (m) |
| 2023-03-31 | (m) | $3.67M | $15.30M | (m) | $152.00K | (m) | (m) |
| 2022-12-31 | (m) | $1.38M | $20.20M | (m) | $76.00K | (m) | (m) |
| 2022-09-30 | (m) | $1.39M | $13.27M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $1.28M | $15.57M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $1.38M | $28.68M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $2.01M | $30.27M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $1.68M | $33.79M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $964.00K | $36.01M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $721.00K | $37.36M | (m) | $0.00 | (m) | (m) |
| 2020-12-31 | (m) | $829.00K | $18.84M | (m) | $0.00 | (m) | (m) |
| 2020-09-30 | (m) | $658.00K | $17.66M | (m) | $19.00K | (m) | (m) |
| 2020-06-30 | (m) | $835.00K | $24.79M | (m) | $84.00K | (m) | (m) |
| 2020-03-31 | (m) | $1.81M | $27.36M | (m) | $111.00K | $0.00 | (m) |
| 2019-12-31 | (m) | $2.36M | $30.47M | (m) | $165.00K | $0.00 | (m) |
| 2019-09-30 | (m) | $3.12M | $30.35M | (m) | $619.00K | $351.00K | (m) |
| 2019-06-30 | (m) | $3.54M | $35.49M | (m) | $538.00K | $506.00K | (m) |
| 2019-03-31 | (m) | $3.74M | $36.48M | (m) | $503.00K | $490.00K | (m) |
| 2018-12-31 | (m) | $3.41M | $35.22M | (m) | $547.00K | $1.05M | (m) |
| 2018-09-30 | (m) | $3.29M | $37.35M | (m) | $475.00K | $1.04M | (m) |
| 2018-06-30 | (m) | $3.21M | $39.61M | (m) | $628.00K | $1.04M | (m) |
| 2018-03-31 | (m) | $4.66M | $43.73M | (m) | $883.00K | $842.00K | (m) |
| 2017-12-31 | (m) | $4.30M | $47.34M | (m) | $1.17M | $605.00K | (m) |
| 2017-09-30 | (m) | $4.13M | $50.73M | (m) | $1.03M | $496.00K | (m) |
| 2017-06-30 | (m) | $3.69M | $54.97M | (m) | $772.00K | $461.00K | (m) |
| 2017-03-31 | (m) | $6.01M | $62.75M | (m) | $647.00K | $550.00K | (m) |
| 2016-12-31 | (m) | $4.44M | $70.00M | (m) | $1.03M | $328.00K | (m) |
| 2016-09-30 | (m) | $4.22M | $51.72M | (m) | $606.00K | $445.00K | (m) |
| 2016-06-30 | (m) | $3.14M | $53.54M | (m) | $103.00K | $512.00K | (m) |
| 2016-03-31 | (m) | $4.49M | $62.09M | (m) | $259.00K | $334.00K | (m) |
| 2015-12-31 | (m) | $5.50M | $70.03M | (m) | $165.00K | $71.00K | (m) |
| 2015-09-30 | (m) | $5.52M | $76.86M | (m) | $180.00K | $68.00K | (m) |
| 2015-06-30 | (m) | $5.22M | $86.00M | (m) | $132.00K | $69.00K | (m) |
| 2015-03-31 | (m) | $4.76M | $50.14M | (m) | (m) | $66.00K | (m) |
| 2014-12-31 | (m) | $3.72M | $50.03M | (m) | (m) | $69.00K | (m) |
| 2014-09-30 | (m) | $3.11M | $54.39M | (m) | $30.00K | $70.00K | (m) |
| 2014-06-30 | (m) | $3.08M | $44.90M | (m) | $60.00K | $71.00K | (m) |
| 2014-03-31 | (m) | $1.89M | $48.17M | (m) | (m) | $63.00K | (m) |
| 2013-12-31 | (m) | $2.90M | $49.82M | (m) | (m) | $82.00K | (m) |
| 2013-09-30 | (m) | $2.94M | $53.36M | (m) | (m) | $74.00K | (m) |
| 2013-06-30 | (m) | $7.58M | $12.85M | (m) | (m) | $85.00K | (m) |
| 2013-03-31 | (m) | $8.38M | $15.63M | (m) | (m) | $88.00K | (m) |
| 2012-12-31 | (m) | $22.04M | $14.82M | (m) | (m) | $360.00K | (m) |
| 2012-09-30 | (m) | $976.23K | $7.68M | (m) | (m) | $312.18K | (m) |
| 2012-06-30 | (m) | $889.01K | $8.47M | (m) | (m) | $527.25K | (m) |
| 2012-03-31 | (m) | $1.11M | $10.35M | (m) | (m) | $337.40K | (m) |
| 2012-03-16 | (m) | (m) | $10.35M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $753.00 | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | $1.13K | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | $1.77K | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | $107.64K | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $62.51K | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $88.97K | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $141.13K | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $141.00K | (m) | (m) | (m) | (m) |
| 2009-12-15 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2009-12-14 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |